Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

188 results about "Doxycycline hydrochloride" patented technology

Doxycycline Hydrochloride is the hydrochloride salt form of doxycycline exhibiting antimicrobial activity. Doxycycline blocks binding of aminoacyl-tRNA to the mRNA-ribosome complex, thereby inhibiting protein synthesis. In addition, this agent has exhibited inhibition of collagenase activity.

Treatment method of waste liquor obtained after alcohol mother liquor purifying in doxycycline hydrochloride production

The invention discloses a treatment method of waste liquor obtained after alcohol mother liquor purifying in doxycycline hydrochloride production. The treatment method comprises the following steps: (1) cooling: stirring and cooling the waste liquor to 40-45 DEG C in a regulating reservoir; (2) performing primary flocculation and sedimentation: adding a flocculating agent into cooled wastewater, and adding alkaline to neutralize after performing the flocculation and sedimentation, and mud-water separation; (3) performing secondary flocculation and sedimentation: performing filter-pressing on the liquid neutralized in the step (2) by virtue of a filter press, performing flocculation and sedimentation on filtrate again, and separating mud from water; (4) performing biochemical treatment: performing biochemical reaction on liquid supernatant obtained by mud-water separation through an ozone oxidation decoloration unit, an anaerobic treatment unit and an aerobic biochemical unit; (5) filtering and performing membrane separation: treating the liquid treated in the step (4) through a membrane bioreactor, a nanofiltration membrane and a reverse osmosis membrane. Compared with the prior art, the treatment method has the beneficial effects of high treatment efficiency, stable operation and capacity of eliminating the pollution of wastewater on the environment.
Owner:ZHONGYUAN ENGINEERING COLLEGE

Method for preparing standard substance for detecting antibiotics in cosmetics

The invention relates to a method for preparing a standard substance for detecting antibiotics in cosmetics. The standard substance is formed by mixing aqueous solution of the antibiotics or solution of propylene glycol and cosmetic cream, wherein the cosmetic cream comprises the following components in percentage by weight: 73 to 78 percent of de-ionized water, 3 to 3.5 percent of propylene glycol and 0.2 to 0.25 percent of carbomer in phase A, 4.5 to 5 percent of stearate, 3 to 4 percent of cetyl alcohol and stearyl alcohol and 10 to 14 percent of 26# white oil in phase B and 1.2 to 1.25 percent of phenoxyethanol and ethylhexylglycerin in phase C; and the concentration of the antibiotics in the standard substance reaches 0.1g/100mL. The method has the advantages that: the antibiotics and the cosmetic cream are mixed to form the standard substance for detecting the antibiotics such as minocycline hydrochloride, oxytetracycline dehydrate, tetracycline hydrochloride, chlortetracycline hydrochloride, doxycycline hydrochloride and chloramphenicol in the cosmetic; and the standard substance is the same as a sample of the cosmetic containing the antibiotics in the actual use; thus the detection of the antibiotics in the cosmetic conforms to the state of the actual application better and is more accurate.
Owner:SHANGHAI INST OF MEASUREMENT & TESTING TECH +1

Doxycycline hydrochloride dual-release preparation and preparation method thereof

The invention belongs to the field of pharmaceutical science, and particularly relates to a doxycycline hydrochloride dual-release preparation and a preparation method thereof. The preparation consists of micropills with different release performance, namely the preparation is formed by mixing 50 to 85 weight percent of quick-release micropill and 50 to 15 weight percent of sustained-release micropill. The preparation method comprises the following steps of: preparing micropill cores according to a formula, and preparing the quick-release micropills by using the micropill cores; preparing thesustained-release micropills by using the quick-release micropills; and filling the quick-release micropills and the sustained-release micropills into capsules in a ratio to obtain doxycycline hydrochloride dual-release capsules. Pharmacokinetic experiments in the dual-release capsule bodies indicate that medicines in the doxycycline hydrochloride dual-release capsules can be released twice when the doxycycline hydrochloride dual-release capsules are taken once every day, and the concentration of two-time peaks is close; the concentration peak of medicines in blood plasma is reduced by a dual-release model, the possibility of side effect is reduced, and the compliance of the administration of patients is improved; and due to the adoption of a new formula and a new process, the difference among batches is reduced, and the stability of samples is improved, so the doxycycline hydrochloride dual-release preparation is suitable for industrial production.
Owner:ZHONGSHUAI PHARMA SCI & TECH CO LTD

Method for synthesizing doxycycline hydrochloride intermediate alpha-6-doxycycline through hydrogenation on basis of silica gel rhodium catalyst

The invention discloses a method for synthesizing a doxycycline hydrochloride intermediate alpha-6-doxycycline through hydrogenation on the basis of a silica gel rhodium catalyst. The invention adopts the key technical scheme that the method comprises the following steps: (1), a rhodium complex is loaded on functionalization silica gel to prepare the silica gel rhodium catalyst; (2), the prepared silica gel rhodium catalyst is dispersed into an organic solvent, methacycline or the salt of the methacycline is used as a raw material, hydrogen is introduced, and the reaction lasts for 4 to 12 hours under the conditions that the pressure is 0.4 to 2.5 MPa and the reaction temperature is 40 to 120 DEG C, so that the doxycycline hydrochloride intermediate alpha-6-doxycycline is prepared. The silica gel rhodium catalyst in the invention has high catalytic activity and enantio selectivity and can be used for doxycycline hydrochloride production process, the yield can reach more than 60 percent, the content of beta-isomer is only 0.03 percent to 0.10 percent, the reaction condition is mild, the reaction directionality is excellent, side reactions are less, and the catalyst can be reduced, so that the production cost is lowered and the industrial production is facilitated.
Owner:HENAN NORMAL UNIV

Compound doxycycline-hydrochloride florfenicol sustained-release microsphere suspension injection for veterinary use

The invention belongs to the technical field of veterinary drug preparation, and relates to a compound doxycycline-hydrochloride florfenicol sustained-release microsphere suspension injection for veterinary use. The suspension injection is produced through a preparation technology combining an inclusion technology, a microcapsule technology and a high-pressure homogenization technology. The suspension injection comprises the following ingredients according to W/V: 10-30% of an inclusion material, 5-20% of doxycycline hydrochloride, 5-20% of florfenicol, 2.5-7.5% of a high-molecular capsule material, 0.2-1% of a suspending agent, 0.25-1% of an anti-oxidant, 0.05-0.2% of a metal chelator, 0.1-0.4% of an antiseptic, and the balance injection water. The active ingredients in the injection possess synergic antibacterial effects and obvious sustained release effect, clinic dosing frequency is reduced, the injection does not contain organic solvents, does not stimulate target animals, is small in toxic and side effects, and is capable of controlling respiratory diseases caused by streptococcus suis, actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis, mycoplasma and the like.
Owner:HUAZHONG AGRI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products